MEG3 overexpression modulates proliferation and angiogenic signaling in oral squamous cell carcinoma: An in silico and experimental study - 15/11/26
, Ramya Sekar b, ⁎
, Selvaraj Jayaraman a
, Kalaiselvi Krishnamoorthy c
, Prabhu Shankar Dayasankar d
, Peramaiyan Rajendran a, e 
Abstract |
Oral squamous cell carcinoma (OSCC) is an aggressive malignancy with few reliable molecular markers for diagnosis and prognosis. Long non-coding RNAs (lncRNAs) regulate key oncogenic processes, and maternally expressed gene 3 (MEG3) has been widely described as a tumour suppressor, but its relationship with angiogenic signalling in OSCC remains unclear. In this study, bioinformatic and experimental approaches were combined to examine the role of MEG3 in OSCC. Differentially expressed lncRNAs were identified from the GEO datasets GSE139869 and GSE160042 using GEO2R, and intersection analysis identified 27 common lncRNAs, from which MEG3 was prioritised. TCGA head and neck squamous cell carcinoma data showed reduced MEG3 expression in tumour tissue compared with normal tissue. Protein–protein interaction analysis of 93 predicted MEG3 target genes identified ten hub genes: AKT1, CRK, CRKL, FGFR1, FLT1, PDGFRA, PDGFRB, PIK3R1, PTPN11 and VEGFA. In vitro, MEG3 overexpression in KB cells increased cell viability, S-phase progression (27.60% vs 12.33%), and VEGF and bFGF protein and mRNA expression. However, MEG3 showed no significant correlation with VEGF or bFGF in TCGA data. In patient plasma, MEG3 expression decreased while VEGF and bFGF expression increased progressively from healthy controls to oral epithelial dysplasia to OSCC (n = 25 per group), with significant differences in the OSCC group. These findings suggest that MEG3 is dysregulated in OSCC and may influence proliferative and angiogenesis-related signalling, although a direct regulatory relationship has not been established. Loss-of-function and functional angiogenesis studies in multiple OSCC models are needed to define its precise role.
Le texte complet de cet article est disponible en PDF.Keywords : MEG3, Oral squamous cell carcinoma, lncRNA, Angiogenesis, VEGF signaling, Bioinformatics analysis
Plan
Vol 127 - N° 6
Article 103074- décembre 2026 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
